Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
暂无分享,去创建一个
D. Borderie | J. Souberbielle | A. Kahan | C. Cormier | É. Sarfati | E. Koumakis | E. Maury | M. Meunier | E. Gallimard
[1] J. Sáez. Primary Hyperparathyroidism Focused on Molecular Pathogenesis. , 2014 .
[2] M. Muñoz-Torres,et al. Normocalcemic primary hyperparathyroidism: one-year follow-up in one hundred postmenopausal women , 2012, Endocrine.
[3] Tracy S. Wang,et al. Surgical Management of Normocalcemic Primary Hyperparathyroidism , 2012, World Journal of Surgery.
[4] S. Silverberg,et al. Normocalcemic primary hyperparathyroidism. , 2010, Arquivos brasileiros de endocrinologia e metabologia.
[5] J. Miller,et al. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] B. Eisner,et al. Differentiating primary from secondary hyperparathyroidism in stone patients: the "thiazide challenge". , 2009, Journal of endourology.
[7] L. Mosekilde,et al. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.
[8] K. Albain,et al. Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] F. Arrieta,et al. Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion , 2008, Journal of endocrinological investigation.
[10] E. Siris,et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. , 2008, The Journal of clinical endocrinology and metabolism.
[11] L. Mosekilde,et al. Primary hyperparathyroidism and the skeleton , 2008, Clinical endocrinology.
[12] P. Vestergaard,et al. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism , 2008, Clinical endocrinology.
[13] M. Rubin,et al. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. , 2007, The Journal of clinical endocrinology and metabolism.
[14] O. Tørring,et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. , 2007, The Journal of clinical endocrinology and metabolism.
[15] G. Divine,et al. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. , 2004, The Journal of clinical endocrinology and metabolism.
[16] M. Hochberg,et al. Treatment With Once‐Weekly Alendronate 70 mg Compared With Once‐Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double‐Blind Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] P. Houillier,et al. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. , 2003, The Journal of clinical endocrinology and metabolism.
[18] F. Melsen,et al. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. , 1999, Bone.
[19] E. Siris,et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. , 1999, The New England journal of medicine.
[20] F. Melsen,et al. Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. , 1999, Bone.
[21] S. Silverberg,et al. To Treat or Not To Treat: Conclusions from the NIH Consensus Conferencea , 1999 .
[22] Judith E. Adams,et al. Bone Loss in Celiac Disease Is Related to Secondary Hyperparathyroidism , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] E. Thurfjell,et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. , 1997, Surgery.
[24] J. Nordenström,et al. Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. , 1995, The European journal of surgery = Acta chirurgica.
[25] E. Siris,et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. , 1995, The Journal of clinical endocrinology and metabolism.
[26] J. Monchik,et al. Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism. , 1992, Surgery.
[27] T. Clemens,et al. Skeletal disease in primary hyperparathyroidism , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] B. Hollis,et al. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. , 1989, The Journal of clinical endocrinology and metabolism.
[29] C. Pak,et al. Sequential Changes in Bone Density Before and After Parathyroidectomy in Primary Hyperparathyroidism , 1982, Investigative radiology.
[30] H. Rasmussen,et al. PRIMARY HYPERPARATHYROIDISM WITH INTERMITTENT HYPERCALCAEMIA: SERIAL OBSERVATIONS AND SIMPLE DIAGNOSIS BY MEANS OF AN ORAL CALCIUM TOLERANCE TEST , 1980, Clinical Endocrinology.
[31] B. Clarke,et al. Surgery or Surveillance for Mild Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Clinical Trial , 2008 .
[32] Ph.D. Erik Nordenström M.D.,et al. Recovery of Bone Mineral Density in 126 Patients after Surgery for Primary Hyperparathyroidism , 2004, World Journal of Surgery.
[33] S. Silverberg,et al. Therapeutic controversies in primary hyperparathyroidism. , 1999, The Journal of clinical endocrinology and metabolism.
[34] J. Firpo,et al. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. , 1973, The Journal of clinical investigation.